A valve-in-valve approach to manage severe bioprosthetic tricuspid valve stenosis  

作　　者：Dominika M Zoltowska Naji Maaliki Bashar Al-Turk Andres M Pineda Maldonado Srinivasan Sattiraju 

机构地区：[1]Cardiology,University of Florida College of Medicine-Jacksonville,Florida,USA [2]Internal Medicine,University of Florida College of Medicine-Jacksonville,Florida,USA

出　　处：《Journal of Geriatric Cardiology》2021年第5期400-402,共3页老年心脏病学杂志（英文版）

摘　　要：severe symptomatic tricuspid stenosis often requires intervention.When the etiology is bioprosthetic valve failure,a challenging situation is met.Surgical valve replacement is the gold standard of treatment for severe tricuspid valve(TV)disease.[1]However,a redo sternotomy is rarely performed for isolated TV disease due to very high perioperative mortality.[2]Evolving percutaneous technology presents new frontiers in treatment,with the valveinvalve procedure emerging as an alternative.We present a case of a 65year woman with progressive symptoms due to failure of a bioprosthetic valve in the tricuspid position who was not a surgical candidate but underwent percutaneous intervention with significant clinical improvement.

关 键 词：TRICUSPID STENOSIS MORTALITY 

分 类 号：R654.2[医药卫生—外科学]